Hwoei Fen Soo Hoo

Management of advanced prostate cancer in a middle‐income country: real‐world consideration of the Advanced Prostate Cancer Consensus Conference 2017

M. M. Abdullah, A. Razack, Jasmine Lim, 2019, BJU international.

Zolbetuximab + CAPOX in 1L claudin-18.2+ (CLDN18.2+)/HER2− locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW.

J. Ajani, P. Sunpaweravong, Y. Bang, 2023, Journal of Clinical Oncology.

Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer Treated in the Neoadjuvant Setting

G. Bonamy, M. Derde, X. Pivot, 2022, JAMA oncology.

Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

J. Ajani, P. Sunpaweravong, Y. Bang, 2023, Nature Medicine.